![Nathan Mata](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan Mata
Directeur Technique/Scientifique/R&D chez
BELITE BIO, INC
Fortune : 3 M $ au 30/06/2026
Profil
Nathan L.
Mata is the founder of ReVision Therapeutics, Inc., founded in 2010, where the title held was Chief Scientific Officer from 2010 to 2012.
Dr. Mata was the founder of Sytera, Inc., founded in 2004, where the title held was Director from 2004 to 2006.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio LLC since 2021.
Dr. Mata currently holds the position of Chief Scientific Officer at Belite Bio, Inc. since 2021.
Former jobs include COO, Director-Research & Development Section at Trethera Corp.
from 2015 to 2017; Chief Scientific Officer, Senior VP-R&D Sector at Sirion Therapeutics, Inc. from 2008 to 2010; and Principal at Jules Stein Eye Institute.
Education includes undergraduate, graduate, and doctorate degrees from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BELITE BIO, INC. 0,07 % | 07/05/2026 | 16 666 ( 0,07 % ) | 3 M $ | 30/06/2026 |
Postes actifs de Nathan Mata
| Sociétés | Poste | Début |
|---|---|---|
| BELITE BIO, INC | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Belite Bio LLC
 Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Directeur Technique/Scientifique/R&D | 01/08/2021 |
Anciens postes connus de Nathan Mata
| Sociétés | Poste | Fin |
|---|---|---|
Trethera Corp.
 Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases | Directeur des opérations | 01/01/2017 |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases | Fondateur | 01/01/2012 |
Sirion Therapeutics, Inc.
 Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Directeur Technique/Scientifique/R&D | 01/01/2010 |
Sytera, Inc.
 Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products | Fondateur | 01/01/2006 |
Jules Stein Eye Institute
 Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute | Corporate Officer/Principal | - |
Formation de Nathan Mata
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
ReVision Therapeutics, Inc.
ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade Develops drugs for the treatment of age-related macular degeneration diseases | Retail Trade |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Health Technology |
Sytera, Inc.
Sytera, Inc. BiotechnologyHealth Technology Provides biopharmaceutical services and products | Health Technology |
Jules Stein Eye Institute
Jules Stein Eye Institute Other Consumer ServicesConsumer Services Operates as eye institute | Consumer Services |
Trethera Corp.
Trethera Corp. Pharmaceuticals: MajorHealth Technology Develops molecule therapies for autoimmune and cancer diseases | Health Technology |
Belite Bio LLC
Belite Bio LLC Pharmaceuticals: MajorHealth Technology Operates clinical stage biopharmaceutical drug development company | Health Technology |
Belite Bio, Inc.
 Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
